Because this range allows optimal ARID1A analysis in our tumor lysate dilutions, we consequently performed specificity analyses in ARID1A wild-type and knockout cell lysates, which revealed a significant decrease in ARID1A concentration in the three subcellular fractions, cytosol, free nucleus, and chromatin. The gene discussed is ARID1A; the disease is neoplasm.